MACHINE LEARNING-BASED QSAR MODELING OF TRICLOSAN ANALOGS FOR ANTIPLASMODIAL ACTIVITY PREDICTION USING SHRINKAGE REGRESSION MODEL AND TOPOLOGICAL-PHYSICOCHEMICAL DESCRIPTORS
Aug 2026· World Journal of Advanced Research and Reviews· Vol 31, pp. 743-752· 0 citations
TL;DR
The RFECV–Ridge QSAR framework provides a reliable and interpretable approach for virtual screening and rational design of novel pfENR inhibitors and highlights the importance of carefully selected descriptors in improving both interpretability and accuracy.
Abstract
Drug-resistant Plasmodium falciparum continues to threaten malaria control, necessitating new antimalarial discovery strategies. QSAR modeling with machine learning offers a cost-effective approach to relate molecular features to biological activity and prioritize candidate compounds for further development. In particular, topological descriptors (capturing molecular connectivity, branching, and structural arrangement) and physicochemical descriptors (such as hydrophobicity, electronic properties, polarity, and steric effects) provide complementary and mechanistically meaningful information governing ligand–target interactions and biological response. Here, a ridge regression QSAR model was developed to predict the anti-plasmodial activity of triclosan analogs. RFECV (Recursive Feature Elimination with Cross-Validation) was used for optimal descriptor selection. The model achieved an R² of 88.83% on the training set and an R²_test of 80.80% on the external test set, indicating strong predictive performance and robust generalization. These results highlight the importance of carefully selected descriptors in improving both interpretability and accuracy. Overall, the RFECV–Ridge QSAR framework provides a reliable and interpretable approach for virtual screening and rational design of novel pfENR inhibitors.
New insights are provided into the structure–property relationships of bipolar disorder drugs and a foundation for future studies using larger molecular data sets is established.
Özge Çolakoğlu, A. Benjamin· ACS Omega· 0 citations
Breast cancer still ranks to be one of the primary causes of cancer-related death worldwide, underscoring the critical need for innovative targeted treatment agents with enhanced safety and efficacy. The current work examined Thienopyrimidinone-based derivatives as possible EGFR inhibitors for breast cancer treatment u...
Shashikant V. Bhandari, Rutuja R. Napte, S. Patil et al.· Bioorganic chemistry (Print)· 0 citations
Inhibiting the formation of haemozoin remains a robust, non-genomic target for antiplasmodial drug discovery. While current efforts focus on multistage active compounds that are not pure haemozoin formation inhibitors, this class offers advantages including selectivity for Plasmodium and is associated with lowered resi...
Nicole Teixeira, Leah Amod, Clinton G. L. Veale et al.· RSC Medicinal Chemistry· 0 citations
This work shows that explainable machine learning offers accurate and interpretable molecular toxicity predictions to enable compound prioritization and computational chemical-safety assessment.
S. Kulkarni· IJRDO - journal of applied s...· 0 citations
Cytochrome P450 (CYP450) enzymes are involved in drug metabolism and pharmacokinetic behaviour and therefore prediction of CYP inhibition early in the drug discovery process is critical to reduce adverse drug reactions and late-stage drug failure. Earlier machine learning investigations achieved prediction accuracy of...